Aglaia BioMedical Ventures combines its focus on oncology with disciplined financing and a hands-on involvement – up to the level of strategic and operational management – to ensure focus on value creation and capital efficiency: keys to success for early stage companies. New additions to our team should bring complimentary scientific as well as clinical, legal, financial and business development expertise to the company.
If you are interested, please send us your details and a CV to email@example.com.
Inthera Bioscience AG expands management team with seasoned professionals and secures €4.7 million second tranche of €9.6 million Series A financing
InteRNA Demonstrates Preclinical Proof-of-Concept for Lead microRNA Candidate INT-1B3 in a Range of Cancer Models at 2018 AACR Annual Meeting